TOKYO -- Japanese chemical and materials maker AGC said Thursday it has teamed up with an Osaka University-affiliated biotechnology company to help produce a coronavirus vaccine that offers a great mass-manufacturing advantage.
Coronavirus
Japan's AGC joins project to develop coronavirus DNA vaccine
Collaboration led by biotech venture hopes to have trials out this summer
Seattle-based AGC Biologics will supply a component for the vaccine underdevelopment. (Photo provided by AGC Biologics)
Read Next
Latest on Coronavirus
